Lilly launches first dog drug

Share this article:
Eli Lilly has launched its first prescription drug for pets in the US, a beef flavored chewable tablet that helps treat dogs for separation anxiety. The drug, marketed under the name Reconcile, uses the same compound as Lilly’s blockbuster antidepressant Prozac. Reconcile is designed to be used in combination with behavior management training to help dogs that have difficulty being separated from their owner or family members. “It basically calms the dog and makes it more receptive to the training that’s supposed to go along with it,” Lilly veterinarian Steve Connell, told the Associated Press. Revenue projections and pricing for Reconcile were not made available. Reconcile has one competitor on the market Clomicalm, which is made my Novartis.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.